Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy
- PMID: 21909123
 - PMCID: PMC4002725
 - DOI: 10.1038/aps.2011.103
 
Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy
Abstract
The cell cycle, which is precisely controlled by a number of regulators, including cyclins and cyclin-dependent kinases (CDKs), is crucial for the life cycle of mammals. Cell cycle dysregulation is implicated in many diseases, including cancer. Recently, compelling evidence has been found that microRNAs play important roles in the regulation of cell cycle progression by modulating the expression of cyclins, CDKs and other cell cycle regulators. Herein, the recent findings on the regulation of the cell cycle by microRNAs are summarized, and the potential implications of miRNAs in anti-cancer therapies are discussed.
Figures
References
- 
    
- Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501–12. - PubMed
 
 - 
    
- Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153–66. - PubMed
 
 - 
    
- He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522, 31. - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
              